Monday 12 October 2026 Export all AMGN data to Excel Powerpack

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

414.87 7.43 +1.82%
Market cap
$224.3B
P/E
25.6×
Fwd P/E
22.7×
Dividend yield
2.40%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
14.61 67.30 15.34 18.62 18.56 21.72 21.48 23.68 34.20 22.84
Piotroski F-Score
8 6 8 6 6 6 6 5 5 7
P/S ratio
4.90 5.66 5.42 6.24 5.30 4.94 5.35 5.64 4.19 4.79
Altman Z-Score
2.62 2.61 2.36 2.29 2.10 1.83 1.77 1.34 1.26 1.69
Altman Z″-Score (non-manufacturers)
4.43 4.44 2.78 0.74 1.04 0.43 0.27 0.53 0.05 0.14
P/FCF ratio
12.28 12.84 12.71 18.01 14.25 16.14 16.86 22.98 14.05 22.97
Beneish M-Score
(2.65) (3.02) (2.62) (2.18) (2.65) (2.65) (2.63) (2.26) (2.83) (2.27)
P/Operating CF
36.37 42.96 40.29 58.01 62.58 45.67 53.14 295.73 29.34 109.85
Dividend Safety Score
— — — — — — — — — 56
P/B ratio
3.77 5.13 10.29 15.08 14.32 19.14 38.45 25.53 23.82 20.34
Price to Tangible BV
23.27 69.15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
4.75 5.39 5.61 7.14 6.18 5.91 6.47 7.55 5.63 6.03
EV/EBITDA
9.18 10.32 10.92 14.04 12.33 13.91 13.13 16.60 14.46 14.34
EV/Operating CF
10.55 11.01 11.80 18.23 14.96 16.58 17.53 25.12 16.37 22.25
EV/FCF
11.90 12.21 13.17 20.60 16.61 19.32 20.41 30.73 18.88 28.90
Quick Ratio
3.68 4.98 2.44 1.01 1.30 1.06 0.95 0.99 0.81 0.73
Current Ratio
4.11 5.49 2.79 1.44 1.81 1.59 1.41 1.65 1.26 1.14
Net Debt/EBITDA
(0.29) (0.53) 0.38 1.77 1.75 2.29 2.28 4.19 3.70 2.94
Debt/Assets
44.57% 44.20% 51.09% 50.08% 52.40% 54.46% 59.80% 66.51% 65.44% 60.28%
Debt/Equity
1.16 1.40 2.71 3.09 3.51 4.97 10.64 10.37 10.23 6.31
Asset Turnover
0.31 0.29 0.32 0.37 0.41 0.42 0.42 0.35 0.35 0.40
Operating CF/Net income
1.34 5.65 1.35 1.17 1.45 1.57 1.48 1.26 2.81 1.29
Capex/Depreciation
(0.35) (0.34) (0.38) (0.28) (0.17) (0.26) (0.27) (0.23) (0.19) (0.29)
Interest Coverage
7.77 7.65 7.37 7.51 7.24 6.38 6.80 2.75 2.30 3.30
ROE
26.65% 7.18% 44.48% 70.73% 76.13% 73.16% 126.47% 135.79% 67.55% 106.10%
ROA
10.36% 2.51% 11.47% 12.44% 11.84% 9.50% 10.38% 8.28% 4.33% 8.45%
ROIC
23.20% 32.97% 37.46% 19.72% 17.99% 14.93% 17.95% 8.24% 8.40% 10.48%
Return on Tangible Assets
19.42% 4.35% 28.86% 74.45% 50.51% 47.58% 54.94% 37.57% 32.79% 67.16%
Average Days of Receivables
50.25 51.71 55.03 63.39 64.96 68.77 77.14 94.11 74.06 95.05
Research and Development Expense of Revenue
16.70% 15.59% 15.74% 17.62% 16.55% 18.55% 16.84% 16.97% 17.84% 19.79%
Selling, General and Administrative Expense of Revenue
22.02% 21.31% 22.45% 22.04% 22.54% 20.66% 20.57% 21.92% 21.23% 19.18%
Intangible Assets out of Total Assets
0.32 0.29 0.33 0.57 0.50 0.49 0.49 0.53 0.50 0.45
Share Based Compensation of Revenue
1.35% 1.44% 1.31% 1.32% 1.30% 1.31% 1.52% 1.53% 1.59% 1.34%
Graham Net Nets
(0.02) (0.04) (0.13) (0.22) (0.24) (0.27) (0.28) (0.38) (0.41) (0.30)
Graham Number
96.30 45.20 73.48 68.25 66.90 52.34 43.18 57.38 43.32 72.03
Earnings Yield
6.85% 1.49% 6.52% 5.37% 5.39% 4.61% 4.66% 4.22% 2.92% 4.38%
Free Cash Flow Yield
8.14% 7.79% 7.87% 5.55% 7.02% 6.20% 5.93% 4.35% 7.12% 4.35%
Revenue per Share
30.74 31.26 35.93 38.61 43.39 45.58 48.93 52.69 62.24 68.31
Operating CF per Share
13.84 15.29 17.09 15.12 17.91 16.25 18.07 15.83 21.40 18.51
Capex per Share
(0.99) (0.91) (1.12) (1.02) (1.04) (1.54) (1.74) (2.08) (2.04) (3.45)
Free Cash Flow per Share
12.86 14.38 15.97 14.10 16.88 14.70 16.33 13.76 19.36 15.06
Cash per Share
50.92 57.02 44.33 14.73 18.17 14.10 17.30 20.46 22.30 16.97
Shareholders Equity per Share
39.94 34.53 18.91 15.99 16.06 11.75 6.80 11.65 10.94 16.09
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
39.94 34.53 18.91 15.99 16.06 11.75 6.80 11.65 10.94 16.09
Free Cash Flow
9,616.00 10,513.00 10,558.00 8,532.00 9,889.00 8,381.00 8,785.00 7,359.00 10,394.00 8,100.00
Working Capital
34,806.00 40,456.00 24,130.00 5,605.00 9,491.00 7,201.00 6,499.00 11,940.00 5,931.00 3,568.00
Capital Expenditures
(738.00) (664.00) (738.00) (618.00) (608.00) (880.00) (936.00) (1,112.00) (1,096.00) (1,858.00)
Net Current Asset Value
(1,741.00) (5,237.00) (16,298.00) (31,594.00) (32,395.00) (35,080.00) (39,274.00) (60,590.00) (56,932.00) (52,871.00)
EV/EBIT
11.16 12.34 12.99 17.25 17.19 20.09 17.81 26.94 25.91 24.40
Capex to Sales
0.03 0.03 0.03 0.03 0.02 0.03 0.04 0.04 0.03 0.05
Price to Operating Income
11.51 12.97 12.54 15.08 14.74 16.79 14.72 20.15 19.28 19.39
Other line items
Depreciation/Fixed assets
0.42 0.39 0.39 0.45 0.74 0.66 0.63 0.83 0.88 0.80
Cash ROIC
9.38% 10.28% 13.94% 17.60% 18.64% 17.44% 16.92% 9.00% 13.33% 11.19%
Accounts Receivable Turnover
7.46 7.14 6.97 6.12 5.93 5.52 5.03 4.39 4.76 4.50
Accounts Payable Turnover
4.42 3.59 3.21 3.38 4.41 4.63 4.36 5.35 7.35 5.63
Inventory Turnover
1.61 1.46 1.42 1.34 1.65 1.62 1.42 1.17 1.56 1.82
Average Days of Payables
80.42 121.28 107.43 114.88 84.21 77.25 89.57 68.67 54.16 71.77
Days of Inventory on Hand
240.73 254.22 261.67 300.31 230.71 231.08 280.90 411.08 198.65 188.76
Average Receivables
3,080.00 3,201.00 3,408.50 3,818.50 4,291.00 4,710.00 5,229.00 6,415.50 7,025.00 8,176.00
Average Payables
941.00 1,134.50 1,279.50 1,289.00 1,396.00 1,393.50 1,469.00 1,581.00 1,749.00 2,137.50
Average Inventory
2,590.00 2,789.50 2,887.00 3,262.00 3,738.50 3,989.50 4,508.00 7,224.00 8,258.00 6,611.50
Average Assets
74,537.50 78,790.00 73,185.00 63,061.50 61,327.50 62,056.50 63,143.00 81,137.50 94,496.50 91,212.50
Average Common Equity
28,979.00 27,558.00 18,870.50 11,086.50 9,541.00 8,054.50 5,180.50 4,946.50 6,054.50 7,267.50

Fold the line items

Columns are period end dates